Columbia University - Site 840-125 — New York, New York

Columbia University - Site 840-125 is a clinical research site located in New York, New York, United States 10032.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

Columbia University - Site 840-125 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Thyroid Eye Disease.

Sponsors: Tourmaline Bio, Inc., a Novartis Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New York

Browse all research sites in New York · View every site in New York

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia University - Site 840-125?

Columbia University - Site 840-125 has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia University - Site 840-125 conducted?

Columbia University - Site 840-125 has 1 clinical trials on record, with 1 currently active. Their work covers Thyroid Eye Disease.

Is Columbia University - Site 840-125 accredited by Crixeo Clinical Trials?

Columbia University - Site 840-125 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Columbia University - Site 840-125?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.